McKinnon T - Search Results

1

SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19.

Prendecki M, Clarke C, McKinnon T, Lightstone L, Pickering MC, Thomas DC, McAdoo SP, Willicombe M. Prendecki M, et al. Among authors: mckinnon t. Kidney Med. 2021 Jan-Feb;3(1):54-59.e1. doi: 10.1016/j.xkme.2020.09.010. Epub 2020 Dec 3. Kidney Med. 2021. PMID: 33521621 Free PMC article.

2

Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis.

Mobayen G, Dhutia A, Clarke C, Prendecki M, McAdoo S, Keniyopoullos R, Malik T, Laffan M, Willicombe M, McKinnon T. Mobayen G, et al. Among authors: mckinnon t. Res Pract Thromb Haemost. 2021 Sep 12;5(6):e12582. doi: 10.1002/rth2.12582. eCollection 2021 Aug. Res Pract Thromb Haemost. 2021. PMID: 34532629 Free PMC article.

3

Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy.

Seth R, McKinnon TAJ, Zhang XF. Seth R, et al. Among authors: mckinnon taj. Am J Physiol Heart Circ Physiol. 2022 Jan 1;322(1):H87-H93. doi: 10.1152/ajpheart.00204.2021. Epub 2021 Dec 10. Am J Physiol Heart Circ Physiol. 2022. PMID: 34890277 Free PMC article. Review.

4

Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis.

O'Donnell JS, McKinnon TA, Crawley JT, Lane DA, Laffan MA. O'Donnell JS, et al. Among authors: mckinnon ta. Blood. 2005 Sep 15;106(6):1988-91. doi: 10.1182/blood-2005-02-0792. Epub 2005 May 10. Blood. 2005. PMID: 15886321 Free article.

5

Blocking von Willebrand factor: a novel anti-platelet therapy.

Laffan M, McKinnon TA. Laffan M, et al. Among authors: mckinnon ta. J Thromb Haemost. 2009 Jul;7(7):1152-4. doi: 10.1111/j.1538-7836.2009.03480.x. Epub 2009 May 8. J Thromb Haemost. 2009. PMID: 19426284 Free article. No abstract available.

6

The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs.

Canis K, McKinnon TA, Nowak A, Panico M, Morris HR, Laffan M, Dell A. Canis K, et al. Among authors: mckinnon ta. J Thromb Haemost. 2010 Jan;8(1):137-45. doi: 10.1111/j.1538-7836.2009.03665.x. Epub 2009 Oct 24. J Thromb Haemost. 2010. PMID: 19874459 Free article.

7

Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor.

McKinnon TA, Goode EC, Birdsey GM, Nowak AA, Chan AC, Lane DA, Laffan MA. McKinnon TA, et al. Blood. 2010 Jul 29;116(4):640-8. doi: 10.1182/blood-2010-02-267450. Epub 2010 Apr 23. Blood. 2010. PMID: 20418283 Free article.

8

O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions.

Nowak AA, Canis K, Riddell A, Laffan MA, McKinnon TA. Nowak AA, et al. Blood. 2012 Jul 5;120(1):214-22. doi: 10.1182/blood-2012-02-410050. Epub 2012 Apr 19. Blood. 2012. PMID: 22517896 Free article.

9

Characterisation of von Willebrand factor A1 domain mutants I1416N and I1416T: correlation of clinical phenotype with flow-based platelet adhesion.

McKinnon TA, Nowak AA, Cutler J, Riddell AF, Laffan MA, Millar CM. McKinnon TA, et al. J Thromb Haemost. 2012 Jul;10(7):1409-16. doi: 10.1111/j.1538-7836.2012.04760.x. J Thromb Haemost. 2012. PMID: 22537243 Free article.

10

The von Willebrand factor predicted unpaired cysteines are essential for secretion.

Shapiro SE, Nowak AA, Wooding C, Birdsey G, Laffan MA, McKinnon TA. Shapiro SE, et al. Among authors: mckinnon ta. J Thromb Haemost. 2014 Feb;12(2):246-54. doi: 10.1111/jth.12466. J Thromb Haemost. 2014. PMID: 24283831 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters